Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -5 of 5 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Aprepitant Plus Palonosetron Versus Granisetron in the Prevention of Nausea and the Emesis Induced by Chemotherapy in Patients Treated With Haematopoietic Progenitors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Supportive care, Treatment				Active				18 and over				Other				2006-00055-18 NCT00415103

Last Modified: 1/12/2009 First Published: 7/1/2002


2.		Phase II/III Randomized Study of Ginger for Chemotherapy-Related Nausea in Patients With Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Supportive care				Active				18 and over				NCI				URCC-U1902 URCC-0114, NCI-5857, NCI-P02-0223, NCT00040742

Last Modified: 1/12/2009 First Published: 5/11/2007


3.		Phase III Randomized Study of Different Combinations of Granisetron Hydrochloride, Dexamethasone, Prochlorperazine, Aprepitant, and Palonosetron Hydrochloride in Preventing Delayed Nausea in Women Undergoing Chemotherapy for Chemotherapy-Naive Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Active				18 and over				NCI				URCC-04-02 URCC 0402, URCC-U1105, U1105, NCT00475085


4.		Efficacy and Safety of Aprepitant in Subjects With Multiple Myeloma During and After High-Dose Chemotherapy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care, Treatment				Active				18 and over				Other				EmNa (2001-004956-38) EudraCT-No: 2004-004956-38, NCT00571168

Last Modified: 8/23/2008 First Published: 2/10/2006


5.		Pilot Study of Aprepitant, Granisetron Hydrochloride, and Dexamethasone in Patients With Nausea and Vomiting Due to Therapy Comprising High Dose Cyclophosphamide Prior to Autologous Peripheral Blood Stem Transplantation

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Supportive care, Treatment				Active				Over 18				NCI				WSU-D-2797 WSU-0504001728, NCT00293384

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute